Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins in rheumatology.

Martin Soubrier1, Christian Roux

  • 1Rheumatology Department, G. Montpied Hospital, Place H. Dunant, BP 69, 63003 Clermont-Ferrand, France. msoubrier@chu-clermontferrand.fr

Joint Bone Spine
|November 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare disease care pathways profile in France: leveraging hospital big data to characterize natural history in osteogenesis imperfecta.

JBMR plus·2026
Same author

Long-Term Effects of Rheumatoid Arthritis Treatments on Bone Mineral Density: 8-Year-Follow-Up Data from Real-World Practice.

Journal of clinical medicine·2026
Same author

Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis.

JBMR plus·2026
Same author

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry.

Joint bone spine·2025
Same author

Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancer.

RMD open·2025
Same author

Cartilage turnover, but not novel synovial collagen marker, is associated with joint damage progression in osteoarthritis patients.

Rheumatology (Oxford, England)·2025
Same journal

Greater trochanteric bursal distension with intra-bursal rice bodies: an unusual MRI presentation.

Joint bone spine·2026
Same journal

Evaluating the Impact of a Rheumatologist-led Comorbidity Review in Patients with Inflammatory Arthritis.

Joint bone spine·2026
Same journal

What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update.

Joint bone spine·2026
Same journal

Multimodal imaging evaluation of the entheses in spondyloarthritis.

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update. What's new?

Joint bone spine·2026
See all related articles

Statins effectively reduce cardiovascular risks. While their benefits for rheumatoid arthritis (RA) and osteoporosis are suggested, further research is needed. Patients with RA or lupus should monitor lipids and consider statins if dyslipidemia is present.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Pharmacology

Background:

  • Statins are primary treatments for lipid disorders, reducing cardiovascular disease (CVD) risk.
  • Increased CVD morbidity and mortality are observed in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).
  • Potential benefits of statins in RA and osteoporosis are suggested but not yet confirmed.

Purpose of the Study:

  • To evaluate the role of statins in managing cardiovascular risks associated with RA and SLE.
  • To summarize current recommendations for lipid management in patients with inflammatory autoimmune diseases.

Main Methods:

  • Review of existing literature on statin efficacy in lipid disorders.
  • Analysis of cardiovascular risk factors in patients with RA and SLE.

Related Experiment Videos

  • Assessment of current guidelines for dyslipidemia treatment.

    • Main Results:

    • Statins are proven effective in primary and secondary cardiovascular prevention.
    • Patients with RA and SLE have elevated cardiovascular risks.
    • Current recommendations advise lipid assays and statin therapy for dyslipidemia in these patient groups.

    Conclusions:

    • Statins are crucial for managing dyslipidemia and reducing cardiovascular events.
    • Cardiovascular health monitoring and appropriate statin use are recommended for RA and SLE patients.
    • Further studies are warranted to confirm statin benefits in non-lipid related conditions like RA.